Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional) (345845)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Next deadline: Jul 9, 2023 (Letter of inquiry)

Later deadlines: Aug 9, 2023 (Full proposal), Oct 15, 2023 (Letter of inquiry), Oct 15, 2023 (Letter of inquiry), Nov 15, 2023 (Full proposal), Feb 4, 2024 (Letter of inquiry), Mar 4, 2024 (Full proposal), Jul 5, 2024 (Letter of inquiry), Aug 5, 2024 (Full proposal), Nov 15, 2024 (Full proposal)

Grant amount: Up to US $275,000

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE: All applications are due by 5:00 PM local time of applicant organization.

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription and other drug) and related disorders, prevention of drug use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of drug using behaviors and their consequences including morbidity and mortality, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of drug abuse and HIV.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.